Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...
Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...
Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive results across all three Phase 3 TEMPO trials ...
Clinical trial results are expected by end of 2026 to guide dose selection for future ALS/MND and Parkinson’s studies. Credit ...
In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement pill called levodopa. It transformed the lives of millions of people.
Benztropine, a drug prescribed for tremors in Parkinson’s disease, has shown promise against tuberculosis (TB) in both human cell and mouse models. The corresponding study was published in npj ...
A man expressing sadness with his head in his hands. Image by Tellmeimok. (CC BY-SA 4.0) A man expressing sadness with his head in his hands. Image by Tellmeimok. (CC BY-SA 4.0) A drug used for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results